Comparing clinical and Para-clinical findings and risk factors among COVID-19 survived and deceased patients in north of Iran, 2019-2020
Journal of Mazandaran University of Medical Sciences
; 31(201), 2021.
Article
in Persian
| GIM | ID: covidwho-1766498
ABSTRACT
Background and purpose:
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in December 2019 in China and spread rapidly around the world. The aim of this study was to compare clinical and laboratory findings and disease outcome between survived and deceased COVID-19 patients admitted to Qaemshahr Razi Hospital, Iran. Materials andmethods:
In this retrospective study, demographic, clinical, paraclinical, and treatment information of hospitalized COVID-19 patients were analyzed. Logistic regression analysis was performed using SPSS V25.
9001-60-9; mortality; human diseases; coronavirus disease 2019; diagnosis; emerging infectious diseases; heart diseases; infectivity; intensive care units; kidney diseases; lactate dehydrogenase; pandemics; risk factors; viral diseases; Severe acute respiratory syndrome coronavirus 2; man; Iran; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; high Human Development Index countries; lower-middle income countries; Middle East; West Asia; Asia; death rate; SARS-CoV-2; emerging diseases; emerging infections; coronary diseases; kidney disorders; nephropathy; renal diseases; viral infections
Search on Google
Collection:
Databases of international organizations
Database:
GIM
Type of study:
Prognostic study
Language:
Persian
Journal:
Journal of Mazandaran University of Medical Sciences
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS